First up, Jason breaks down Uber’s huge Q1 results! (1:21) Then, Unlearn.AI CEO Charles Fisher joins to discuss the advancements his company is making in fast-tracking clinical trials (9:49), how machine learning is used in drug development (16:24), Unlearn’s business model (35:24), and more!

(0:00) Jason kicks off the show

(1:21) Uber’s Q1 earnings

(8:31) QuickNode - Get one month free by using code TWIST at https://go.quicknode.com/twist

(9:49) The foundation of Unlearn.AI

(12:42) Unlearn.AI’s impact on the clinical trial process

(14:24) Criticisms of the current clinical trial model

(16:24) ML’s Impact on drug discovery

(24:16) CacheFly - Get 10 terabytes free by signing up at https://twist.cachefly.com

(25:42) The data used in the medical system today

(34:05) Microsoft for Startups Founders Hub - Apply in 5 minutes for six figures in discounts at http://aka.ms/thisweekinstartups

(35:24) Unlearn.AI’s business model

(40:22) Building a foundational model for health

(44:06) The pace of AI today vs. the previous decade

(46:35) More on Unlearn.AI’s business model

(48:15) Creating foundational datasets in health

FOLLOW Charles: https://twitter.com/charleskfisher

FOLLOW Jason: https://linktr.ee/calacanis

Subscribe to our YouTube to watch all full episodes:

https://www.youtube.com/channel/UCkkhmBWfS7pILYIk0izkc3A?sub_confirmation=1

FOUNDERS! Subscribe to the Founder University podcast:

https://podcasts.apple.com/au/podcast/founder-university/id1648407190

Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734

This Week in Startups

Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734